These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8977196)

  • 1. B cell epitope mapping of the bacterial superantigen staphylococcal enterotoxin B: the dominant epitope region recognized by intravenous IgG.
    Nishi JI; Kanekura S; Takei S; Kitajima I; Nakajima T; Wahid MR; Masuda K; Yoshinaga M; Maruyama I; Miyata K
    J Immunol; 1997 Jan; 158(1):247-54. PubMed ID: 8977196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The conventional CD4+ T cell response to staphylococcal enterotoxin B is modified by its superantigenic activity.
    Wen R; Surman S; Blackman MA; Woodland DL
    Cell Immunol; 1997 Mar; 176(2):166-72. PubMed ID: 9073390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous immunoglobulin contains specific antibodies inhibitory to activation of T cells by staphylococcal toxin superantigens [see comment].
    Takei S; Arora YK; Walker SM
    J Clin Invest; 1993 Feb; 91(2):602-7. PubMed ID: 8432865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of specific immunoglobulin production in SCID-hu-PBL mice after in vitro priming of human B cells with superantigen.
    Mårtensson C; Ifversen P; Borrebaeck CA; Carlsson R
    Immunology; 1995 Oct; 86(2):224-30. PubMed ID: 7490122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superantigen-driven, CD8+ T cell-mediated down-regulation: CD95 (Fas)-dependent down-regulation of human Ig responses despite CD95-independent killing of activated B cells.
    Stohl W; Lynch DH; Starling GC; Kiener PA
    J Immunol; 1998 Oct; 161(7):3292-8. PubMed ID: 9759844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of staphylococcal enterotoxin A-induced superantigenic and lethal activities by a monoclonal antibody to toxic shock syndrome toxin-1.
    Kum WW; Chow AW
    J Infect Dis; 2001 Jun; 183(12):1739-48. PubMed ID: 11372026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of mouse liver natural killer cells and NK1.1(+) T cells by bacterial superantigen-primed Kupffer cells.
    Dobashi H; Seki S; Habu Y; Ohkawa T; Takeshita S; Hiraide H; Sekine I
    Hepatology; 1999 Aug; 30(2):430-6. PubMed ID: 10421651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intercellular adhesion molecule-1 and leukocyte function-associated antigen-3 provide costimulation for superantigen-induced T lymphocyte proliferation in the absence of a specific presenting molecule.
    Lamphear JG; Stevens KR; Rich RR
    J Immunol; 1998 Jan; 160(2):615-23. PubMed ID: 9551895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Staphylococcal enterotoxin A induces survival of VH3-expressing human B cells by binding to the VH region with low affinity.
    Domiati-Saad R; Lipsky PE
    J Immunol; 1998 Aug; 161(3):1257-66. PubMed ID: 9686586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD95 (Fas)-based, superantigen-dependent, CD4+ T cell-mediated down-regulation of human in vitro immunoglobulin responses.
    Stohl W; Elliott JE; Lynch DH; Kiener PA
    J Immunol; 1998 Jun; 160(11):5231-8. PubMed ID: 9605118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo staphylococcal enterotoxin B (SEB)-primed murine splenocytes secrete mediators which suppress CD25(hi) expression and cell cycle progression of naive splenocytes in response to SEB in vitro.
    Hsu LJ; Jan MS; Lin YS
    Cell Immunol; 2000 Apr; 201(1):50-7. PubMed ID: 10805973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity of the histidine-to-tyrosine staphylococcal enterotoxin B mutant protein in C3H/HeJ mice.
    Savransky V; Pinelis D; Korolev S; Ionin B; Fegeding K
    Toxicon; 2004 Mar; 43(4):433-8. PubMed ID: 15051407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Administration of superantigens protects mice from lethal Listeria monocytogenes infection by enhancing cytotoxic T cells.
    Okamoto S; Kawabata S; Nakagawa I; Hamada S
    Infect Immun; 2001 Nov; 69(11):6633-42. PubMed ID: 11598032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and characterization of immunodominant B-cell epitope of the C-terminus of protective antigen of Bacillus anthracis.
    Kaur M; Chug H; Singh H; Chandra S; Mishra M; Sharma M; Bhatnagar R
    Mol Immunol; 2009 Jun; 46(10):2107-15. PubMed ID: 19356802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fine-mapping of immunodominant linear B-cell epitopes of the Staphylococcus aureus SEB antigen using short overlapping peptides.
    Zhao Z; Li B; Sun HQ; Zhang JY; Wang YL; Chen L; Hu J; He YF; Zeng H; Zou QM; Wu C
    PLoS One; 2014; 9(3):e90445. PubMed ID: 24599257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms mediating enhanced neutralization efficacy of staphylococcal enterotoxin B by combinations of monoclonal antibodies.
    Dutta K; Varshney AK; Franklin MC; Goger M; Wang X; Fries BC
    J Biol Chem; 2015 Mar; 290(11):6715-30. PubMed ID: 25572397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Staphylococcal enterotoxin B induces an early and transient state of immunosuppression characterized by V beta-unrestricted T cell unresponsiveness and defective antigen-presenting cell functions.
    Muraille E; De Smedt T; Andris F; Pajak B; Armant M; Urbain J; Moser M; Leo O
    J Immunol; 1997 Mar; 158(6):2638-47. PubMed ID: 9058796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor response elicited by a superantigen-transmembrane sequence fusion protein anchored onto tumor cells.
    Wahlsten JL; Mills CD; Ramakrishnan S
    J Immunol; 1998 Dec; 161(12):6761-7. PubMed ID: 9862706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Staphylococcal cell membrane antigen, a possible antigen in post-methicillin resistant Staphylococcus aureus (MRSA) infection nephritis and IgA nephropathy, exhibits high immunogenic activity that is enhanced by superantigen.
    Shimizu Y; Sakurai H; Hirayama K; Seki M; Yoh K; Yamagata K; Koyama A
    J Nephrol; 2005; 18(3):249-56. PubMed ID: 16013011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Superantigen antagonist protects against lethal shock and defines a new domain for T-cell activation.
    Arad G; Levy R; Hillman D; Kaempfer R
    Nat Med; 2000 Apr; 6(4):414-21. PubMed ID: 10742148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.